Primary |
Schizoaffective Disorder |
33.3% |
Depression |
16.7% |
Glucose Tolerance Impaired |
16.7% |
Incontinence |
16.7% |
Salivary Hypersecretion |
16.7% |
|
Multiple Drug Overdose |
50.0% |
Tachycardia |
50.0% |
|
Secondary |
Product Used For Unknown Indication |
20.8% |
Hypertension |
16.7% |
Drug Use For Unknown Indication |
14.6% |
Diabetes Mellitus |
11.5% |
Type 2 Diabetes Mellitus |
9.4% |
Arrhythmia |
5.2% |
Coronary Artery Disease |
4.2% |
Gout |
4.2% |
Hypercholesterolaemia |
4.2% |
Breast Cancer |
3.1% |
Insomnia |
2.1% |
Anticoagulant Therapy |
1.0% |
Back Pain |
1.0% |
Depression |
1.0% |
Device Therapy |
1.0% |
|
Pruritus |
25.0% |
Peripheral Vascular Disorder |
16.7% |
Pulse Absent |
16.7% |
Angioplasty |
8.3% |
Hypotension |
8.3% |
Parkinson's Disease |
8.3% |
Proteinuria |
8.3% |
Urinary Tract Infection |
8.3% |
|
Concomitant |
Hypertension |
20.5% |
Diabetes Mellitus |
16.2% |
Type 2 Diabetes Mellitus |
14.1% |
Product Used For Unknown Indication |
11.4% |
Drug Use For Unknown Indication |
8.6% |
Coronary Artery Disease |
3.1% |
Depression |
2.8% |
B-cell Lymphoma |
2.6% |
Rheumatoid Arthritis |
2.5% |
Colon Cancer Metastatic |
2.3% |
Prophylaxis |
2.3% |
Dyslipidaemia |
2.2% |
Cardiac Failure |
1.8% |
Chronic Obstructive Pulmonary Disease |
1.7% |
Atrial Fibrillation |
1.5% |
Hyperlipidaemia |
1.3% |
Pain |
1.3% |
Psoriasis |
1.3% |
Cardiac Failure Chronic |
1.2% |
Ill-defined Disorder |
1.2% |
|
Vomiting |
14.1% |
Weight Increased |
7.7% |
Drug Eruption |
6.4% |
Renal Failure |
6.4% |
Sepsis |
6.4% |
Syncope |
6.4% |
Weight Decreased |
6.4% |
Diabetes Mellitus |
5.1% |
Myocardial Infarction |
5.1% |
Shock |
5.1% |
Hyponatraemia |
3.8% |
Pulmonary Embolism |
3.8% |
Pyrexia |
3.8% |
Tricuspid Valve Incompetence |
3.8% |
Acute Myocardial Infarction |
2.6% |
Anaphylactic Shock |
2.6% |
Atrioventricular Block Complete |
2.6% |
Blood Pressure Increased |
2.6% |
Bronchopneumonia |
2.6% |
Central Nervous System Inflammation |
2.6% |
|
Interacting |
Diabetes Mellitus |
50.0% |
Hypertension |
50.0% |
|
|